221 related articles for article (PubMed ID: 24911578)
1. Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants.
Morita T; Senzaki K; Ishihara R; Umeda K; Iwata N; Nagai T; Hida H; Nabeshima T; Yukawa K; Ozaki N; Noda Y
Hum Psychopharmacol; 2014 May; 29(3):280-6. PubMed ID: 24911578
[TBL] [Abstract][Full Text] [Related]
2. Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression.
Hsiao CC
Psychoneuroendocrinology; 2006 Aug; 31(7):839-46. PubMed ID: 16716529
[TBL] [Abstract][Full Text] [Related]
3. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls.
Kurita H; Maeshima H; Kida S; Matsuzaka H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H
J Affect Disord; 2013 Apr; 146(2):205-12. PubMed ID: 23102506
[TBL] [Abstract][Full Text] [Related]
4. Higher serum DHEA concentrations before and after SSRI treatment are associated with remission of major depression.
Hough CM; Lindqvist D; Epel ES; Denis MS; Reus VI; Bersani FS; Rosser R; Mahan L; Burke HM; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2017 Mar; 77():122-130. PubMed ID: 28038403
[TBL] [Abstract][Full Text] [Related]
5. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
6. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
[TBL] [Abstract][Full Text] [Related]
7. Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings.
Assies J; Visser I; Nicolson NA; Eggelte TA; Wekking EM; Huyser J; Lieverse R; Schene AH
Psychiatry Res; 2004 Sep; 128(2):117-22. PubMed ID: 15488954
[TBL] [Abstract][Full Text] [Related]
8. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R
J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658
[TBL] [Abstract][Full Text] [Related]
9. Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.
Paslakis G; Luppa P; Gilles M; Kopf D; Hamann-Weber B; Lederbogen F; Deuschle M
J Psychiatr Res; 2010 Jun; 44(8):556-60. PubMed ID: 20022345
[TBL] [Abstract][Full Text] [Related]
10. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
11. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
[TBL] [Abstract][Full Text] [Related]
12. Positive correlation between anxiety severity and plasma levels of dehydroepiandrosterone sulfate in medication-free patients experiencing a major episode of depression.
Hsiao CC
Psychiatry Clin Neurosci; 2006 Dec; 60(6):746-50. PubMed ID: 17109709
[TBL] [Abstract][Full Text] [Related]
13. Characterising anxiety in major depressive disorder and its use in predicting antidepressant treatment outcome: An iSPOT-D report.
Braund TA; Palmer DM; Williams LM; Harris AW
Aust N Z J Psychiatry; 2019 Aug; 53(8):782-793. PubMed ID: 30880405
[TBL] [Abstract][Full Text] [Related]
14. Plasma galanin is a biomarker for severity of major depressive disorder.
Wang YJ; Yang YT; Li H; Liu PZ; Wang CY; Xu ZQ
Int J Psychiatry Med; 2014; 48(2):109-19. PubMed ID: 25377152
[TBL] [Abstract][Full Text] [Related]
15. Residual anxiety symptoms in depressed primary care patients.
McIntyre RS; Konarski JZ; Soczynska JK; Kennedy SH
J Psychiatr Pract; 2007 Mar; 13(2):125-8. PubMed ID: 17414691
[TBL] [Abstract][Full Text] [Related]
16. Lowered DHEA-S plasma levels in adult individuals with autistic disorder.
Strous RD; Golubchik P; Maayan R; Mozes T; Tuati-Werner D; Weizman A; Spivak B
Eur Neuropsychopharmacol; 2005 May; 15(3):305-9. PubMed ID: 15820420
[TBL] [Abstract][Full Text] [Related]
17. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
18. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth.
Suri R; Altshuler L; Hellemann G; Burt VK; Aquino A; Mintz J
Am J Psychiatry; 2007 Aug; 164(8):1206-13. PubMed ID: 17671283
[TBL] [Abstract][Full Text] [Related]
19. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
Huang TL; Lee CT; Liu YL
J Psychiatr Res; 2008 Jun; 42(7):521-5. PubMed ID: 17585940
[TBL] [Abstract][Full Text] [Related]
20. Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS.
Rabkin JG; McElhiney MC; Rabkin R; McGrath PJ; Ferrando SJ
Am J Psychiatry; 2006 Jan; 163(1):59-66. PubMed ID: 16390890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
